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Summary 
O B J E C T I V E S leeping s i c k n e s s (African t rypanosomiasis) 
is an anthropozoonosis transmitted by the tsetse fly. The 
treatments of choice are the antiparasitic agents suramin 
and/or melarsoprol . Experimental infection of an imals 
with Trypanosoma brucei resul ts in inflammatory les ions 
in the pituitary and/or the thyroid gland. In biochemical 
terms, these an imals have hypothyroidism. We evaluated 
the functional integrity of the hypothalamic-pituitary-
thyroid axis in patients with African t rypanosomiasis 
before, during and after specif ic therapy. 
D E S I G N Prospect ive, controlled, c ross-sect iona l study. 
P A T I E N T S A N D M E A S U R E M E N T S Sixty-five patients with 
sleeping s i c k n e s s (31 female, 34 male; aged 18-66; 32 with 
haemolymphatic s leeping s i c k n e s s receiving suramin i.V., 
33 with cerebral s leeping s i c k n e s s receiving melarsoprol) 
and 13 control subjects (6 female, 7 male; aged 21-60) 
were enrolled in a cross-sect iona l study after giving 
informed consent . Fourteen patients were studied shortly 
after admission for s leeping s i c k n e s s , 19 in the middle of 
the course of treatment, 18 at the end of the 5-week 
treatment period, and 14 patients after cure . All subjects 
underwent a T R H stimulation test at 1200 with bolus 
injection of 400 fig T R H i.v. Blood w a s drawn for determi-
nation of fT3 , fT4, T S H , rT3, TNF -a , IL-1 and IL-6 at 0 
minutes and T S H at 60 minutes. All hormones and 
cytokines were determined by RIA or E L I S A . 
R E S U L T S B a s e l i n e T S H concentrat ions (mean ± S E M ) 
were elevated in unmedicated patients with s leeping 
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s i c k n e s s compared to normal subjects (2 6 ± 0 4 vs 
1 4 ± 0 2 mU/l ; P = 0 01), w h e r e a s f T3 (2 7 ± 0 5 vs 5 8 ± 0 3 
pmol/ l; P = 0 0002) and fT4 concentrations (10-3 ± 1 - 2 vs 
15 4 + 0 8 pmol/l; P = 0-007) were low. Stimulated T S H 
concentrat ions did not significantly differ from normal 
controls. R e v e r s e T3 concentration in patients with s leep-
ing s i c k n e s s were normal (2 2 ± 0 3 vs 2-4 ± 0 - 2 nmol/l; 
P = NS) . During the c o u r s e of treatment, basel ine T S H , f T3 
and fT4 concentrat ions slowly returned to normal and 
were indistinguishable from controls after cure . P l a s m a 
concentrat ions of TNF-a (16 0 ± 4 1 vs 2 - 9 ± 1 - 4 ng/l in 
controls; P = 0-003) and interleukin-6 (19 2 ± 7 3 vs 1 3 ± 0 2 
ng/l; P = 0 0001), but not interleukin-1/? (2-0 ± 0 - 2 vs 
0-9 ± 0 - 2 , ng/l P = N S ) , were elevated, when thyroid func-
tion impairment and d i s e a s e activity were at their maxi-
mum, but gradually d e c r e a s e d into the normal range with 
therapy. We found a negative correlation between base -
line cytokine concentrations and fT3 concentrations 
(TNF-a: r= - 0 34, P = 0-003; IL-6: r = - 0 43, P = 0-0001). 
C O N C L U S I O N S We conclude that unmedicated sleeping 
s i c k n e s s is assoc ia ted with significant impairment of 
thyroid function, which is reversed with specif ic therapy. 
Elevated T S H concentrations and low f T3 and f T4 concen-
trations suggest primary hypothyroidism in patients with 
s leeping s i c k n e s s . However, an additional pituitary and/or 
hypothalamic component cannot be excluded. This 
impairment may be due to the elevated p lasma cytokine 
concentrat ions found in these patients or may be the result 
of parasit ic thyroiditis. 
African sleeping sickness (SS) is caused by Trypanosoma 
brucei, an extracellular protozoan parasite transmitted by 
the bite of the tsetse fly (Manson-Bahr & Apted, 1982; 
Hunter et al., 1984). Approximately 20000 new cases are 
reported each year to the WHO, although there is consider-
able fluctuation due to epidemic outbreaks (WHO, 1987; 
1990). Clinically, the early acute disease is characterized by 
haemolymphatic involvement with predominant invasion of 
lymphatic tissue, whereas pancarditis, glomerulonephritis 
and hepatitis are observed less frequently. After invasion of 
the central nervous system by the parasite, a meningoence-
phalitis, with a broad spectrum of neurologic and psychiatric 
symptoms, evolves. Untreated, the disease is fatal and death 
is due to secondary bacterial infection, coma, or cachexia. 
Recent work has pointed to the importance of interaction 
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Tab le 1 Clinical profile of patients and controls 
Sex Haemolymphatic Cerebral Age Time of test after Day time of test 
(female/male) stage stage (mean, range) onset of therapy (mean ± SD) 
n in) (years) (mean, range) (hour/min) 
Normal controls 13 6/7 — — 34 (21-60) — 11-34+105 
Patients shortly after admission 14 5/9 6 8 31 (18-60) 4-0 (2-7) d 12-05 ±1-10 
Patients after 2 weeks of therapy 19 10/9 10 9 36 (21-56) 15 0 (9-22) d 11-45 + 0-53 
Patients after 4 weeks of therapy 18 9/9 10 8 37 (18/65) 28 0 (23-38) d 1200 + 0-55 
Patients after cure 14 in 6 8 39 (20-65) 22 (6-37) mo 11-31+0-53 
d, Days; mo, months. 
between the immune and neuroendocrine system (Imura et 
aL, 1991; Chrousos & Gold, 1992). I t is well known that 
serum thyroid hormone levels change in severe illness 
(Wartofsky & Burman, 1982). Such abnormalities of thyroid 
hormone tests, including low normal TSH, low normal f T4, 
low T3 and high reverse T3, designated 'euthyroid sick 
syndrome', are considered to be partly mediated by the 
effects of the inflammatory cytokines on the hypothalamic-
pituitary-thyroid (HPT) axis. In vivo and in vitro, inter-
leukin-l/i ( I L - l / i ) and tumour necrosis factor-a (TNF-a) 
inhibit TSH secretion as well as thyroid hormone release 
(Dubuis et at., 1988; Van Der Poll et aL, 1990; Ozawa et aL, 
1988), whereas the effects of interleukin-6 (IL-6) on the HPT 
axis have not been studied in detail. 
Endocrine abnormalities in African SS have been 
observed since the early 1950s and include hypothyroidism, 
hypogonadism and mild adrenocortical insufficiency (Apted, 
1953; Ridet, 1953; Emeh & Nduka, 1983; Hublart et aL, 
1988; Reincke et aL, 1992). Patients with SS frequently suffer 
from lethargy, skin pallor, cold intolerance and hypother-
mia, suggestive of hypothyroidism (Noireau et aL, 1988). 
Experimental trypanosomiasis in animals has been asso-
ciated with inflammatory changes in the pituitary and/or the 
thyroid gland (Murray, 1974; Morrison et a/., 1981), and 
goats infected with Trypanosoma Congolese had very low 
thyroxine concentrations (Mutayoba et aL, 1988). The 
pathogenesis of these abnormalities in humans has not been 
elucidated; however, experimental data in animals suggest a 
direct effect of the parasite on the pituitary and/or the 
thyroid gland (Ikede & Losos, 1975). In addition, inflamma-
tory cytokines are elevated in African trypanosomiasis and 
may play a role in the thyroid hormone abnormalities of 
these patients. We investigated the interaction between the 
HPT axis and the inflammatory cytokines TNF-a, IL-1/? and 
IL-6 in 65 patients with African trypanosomiasis and 
compared the results with those of 13 normal Ugandan 
controls. 
Patients and methods 
Patients and controls 
Patients and controls were recruited through the National 
Sleeping Sickness Control Program in south-east Uganda. 
The diagnosis of SS was established by microscopical 
demonstration of parasites in the peripheral blood (haemo-
lymphatic stage), and/or in cerebrospinal fluid obtained by 
lumbar puncture (cerebral stage). A l l patients with SS 
received initially a small dosage of suramin (day 1,0-25 g; day 
3, 0*5 g i . V . ) . Thereafter, patients without cerebral involve-
ment (haemolymphatic stage) received weekly 1-g injections 
of suramin up to a total dose of 5-75 g, whereas patients with 
cerebral SS were treated with a 5-week course of melarsoprol 
(total dose: 20 mg/kg body weight). 
A total of 65 patients with Trypanosoma brucei rhodesiense 
infection and 13 healthy Ugandan control subjects were 
studied after giving informed consent (clinical data, see 
Table 1). None of the healthy subjects had a previous history 
of SS, thyroid disease or had received suramin, melarsoprol 
or thyroxine treatment. Using a cross-sectional study design, 
every patient was studied once during the course of treat-
ment, on each of the following occasions: 
(1) while acutely i l l , within the first 7 days from admission to 
the health care centre 
(2) in the middle of the course of treatment (days 9-22) 
(3) at the end of the treatment period (days 23-38) 
(4) after permanent cure (at least 6 months after end of 
treatment) 
The patients had no clinically apparent signs of thyroid 
involvement. None of the patients had a goitre or com-
plained of local tenderness over the thyroid region. 
The study was approved by the ethics committee of the 
University of Köln and by the Ministry of Health, Uganda, 
and post hoc by the ICRS of the N I C H D . 
A l l patients and controls underwent a T R H stimulation 
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test between 1000 and 1400 h. In addition, the patients 
received hCRH (100 fig i . V . ; results reported elsewhere 
(Reincke et aL, 1992)). After placing an indwelling catheter 
in the forearm blood was drawn for determination of TSH, 
T3, T4, rT3 at baseline and 30 minutes after a bolus injection 
of 400 fig T R H i.v. (protirelin, T R H Relefact, Hoechst, 
Frankfurt, FRG). The concentrations of TNF-a, I L - l ß and 
IL-6 were determined in the baseline samples. 
The samples were stored on ice for up to 6 hours, then 
centrifuged and stored at — 20°C. After transportation to 
FRG or USA on dry ice, all samples from a single patient 
were run in the same assay. 
Assays 
Serum TSH was determined in duplicate by a commercial 
two-site immunoradiometric assay (Nichols, Bad Nauheim, 
FRG). The interassay and intra-assay variabilities were 6-8 
and 4-5%, respectively. Free T3 and f T4 concentrations were 
determined directly by 'solid-phase technique' RIAs (Hen-
ning, Berlin, FRG). The interassay and intra-assay variabili-
ties were 9 1 and 5-2%, and 7-4 and 4-5%, respectively. 
Reverse T3 was measured by RIA as described elsewhere 
(Bagni et aL, 1977). The inter and intra-assay variabilities 
were 14-2 and 11 -9%. Cross-reactivities of the antiserum with 
L-thyroxine, L-3,5,3 /-triiodthyronine, L-3,5-diiodothyronine 
and L-3,3'-diiodthyroninc were 008, 0-002, 00006 and 
0 03%, respectively. TNF-a, IL-l/?and IL-6 were determined 
by specific ELISA using commercial assays ( R & D Systems, 
Minneapolis, USA). The lower limits of detection of these 
assays were, respectively, 2-8, 1-0 and 10 ng/l, and the inter 
and intra-assay variability 6-4 and 7-8, 30 and 50, and 7-8 
and 7-5%. 
4 
3 
2 
I 
0 
2 0 
e i o 
r - (a) 
T 
I— (b ) 
*** * 
8 r (c ) 
< 6 
I 4 U 
m 
0 
[— (d ) 
Con Adm 2 wks 4 wks Cure 
Fig . 1 Mean ( + SE) a, baseline T S H ; b, fT4; c, fT3; and d, rT3 
concentrations in 65 African patients with SS and 13 age and sex-
matched controls. C O N , controls; A D M , newly admitted patients 
with SS; 2 W K S , 4 W K S , after 2 and 4 weeks of treatment. The 
symbols denote significant changes between patients and controls. 
*/>^005; **/><0-01; ***P^0005. 
Statistics 
The data of patients with haemolymphatic and cerebral SS 
were analysed separately to exclude effects of disease stage 
and treatment on the HPT axis. Since no significant 
differences were found, the combined data of both groups are 
shown. Al l data are expressed as mean ± SEM, i f not 
otherwise stated. The normal range of hormones and 
peptides was defined as the mean of the controls + 2 standard 
deviations. Differences between group means were assessed 
using a non-parametric one-way A N O V A (Kruskal-Wallis 
test) and the Mann-Whitney cMest for unpaired data, as 
appropriate. Correlations were examined with linear regres-
sion analysis, after logarithmic transformation of cytokine 
concentrations when the arithmetic values did not have a 
Gaussian distribution, and expressed as Pearson's correla-
tion coefficient. P^O-05 was considered as statistically 
significant. 
Resul ts 
Baseline thyroid function 
In 65 patients with SS and 13 age and sex-matched normal 
Ugandan controls baseline TSH, fT3, fT4 and rT3 were 
determined (Fig. 1). For TSH concentrations (Kruskal-
Wallis test, /> = 0-04), fT3 (/^O-OOOl), fT4 ( P = 0 0 1 ) and 
rT3 concentrations (P = 004) significant differences were 
found. Shortly after admission, SS patients had elevated 
TSH concentrations compared to normal controls (2-6 + 0-4 
vs 1-4 + 0-2 mU/1; P = 0-01), whereas fT3 (2-8 ±0-5 vs 
5-4±0-3 pmol/l; P = 0-0002) and f T4 (10-3 + 1 -2 vs 15-4 + 0-8 
pmol/l; P = 0-007) were low and rT3 concentrations normal 
(2-2 ± 0-4 vs 2-4 ± 0 - 3 nmol/1; P = NS). After 2 and 4 weeks of 
treatment, elevated TSH concentrations slowly returned to 
normal. In addition, f T3 and f T4 concentrations increased 
somewhat, but remained subnormal. However, rT3 concen-
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trations were significantly lower in patients with SS than in 
controls after 2 and 4 weeks of treatment. After cure, rT3 
concentrations remained low in patients with SS, whereas 
TSH, f T3 and f T4 concentrations were normal. 
Seven of 14 (50%) patients on admission, 4 of 19 (21%) 
after 2 weeks of treatment, 4 of 18 (22%) after 4 weeks of 
treatment and none of 14 patients after cure had fT4 
concentrations below the normal range of controls (10*0-
20-7 pmol/l). 
TRH stimulation test 
All patients and controls underwent a T R H stimulation test. 
Stimulated TSH concentrations as well as the TSH increase 
did not significantly differ between patients with SS and 
control subjects (Kruskal-Wallis test, P = 0\4 and 013, 
respectively). TSH concentrations after T R H in control 
subjects were 16*8+1-7, in patients with SS shortly after 
admission 17-4 + 2-2, after 2 weeks of treatment 14-8±l -5 , 
after 4 weeks of treatment 13-8 + 2-6, and after cure 17-3 + 2-1 
mU/1, respectively. The corresponding TSH increase was 
15-4+1-6 in controls and 14-8 + 20, 12-8+1-3, 12-5±2-2 
and 15-8 + 2-0 mU/1, respectively, in patients with SS during 
the course of treatment. 
Cytokines 
In all subjects basal circulating TNF-a, \L-\ß and IL-6 
concentrations were determined (Fig. 2a). TNF-a (Kruskal-
Wallis test, P = 0-005) and IL-6 (Kruskal-Wallis test, 
P = 00001), but not I L - l / i , were substantially elevated in SS. 
TNF-a concentrations were high in patients shortly after 
admission (160 + 4-5 vs 2-9 ± 1-4 ng/l in controls, P = 0 003) 
and returned to normal after 2 and 4 weeks of treatment 
(3-8 ±1-6 and 6-5+1-7 ng/l, respectively). A weak, but 
significant, positive correlation was observed between basal 
TNF-a concentrations and basal TSH concentrations in 
patients with SS (r = 0-27, /> = 0*02; Fig. 2b). In addition, 
TNF-a concentrations were inversely correlated with fT3 
concentrations ( r = —0-34, P = 0*003) and, to a lesser degree, 
with fT4 concentrations ( / = —0*23, P = 0-05). TNF-a con-
centrations showed a positive correlation with reverse T3 
levels (/- = 0-26, P =002 ) . 
IL- l / J concentrations were undetectable in most of the 
patients with SS, and mean immunorcactive concentrations 
did not differ from those of control subjects (0*9 + 0-2 rs 
2-0 ±0*8 ng/l, P = NS). 
IL-6 concentrations, on the other hand, were dramatically 
elevated in SS (19*2±7*3 vs 2*9±1*4 ng/l in controls, 
p = 00001) and slowly returned to normal (after 2 weeks, 
16*3+10-8 ng/l; after 4 weeks, 2-8 ± 1*6 ng/l). TSH concen-
trations showed no correlation with IL-6 concentrations. 
Free T3 and fT4 concentrations were negatively correlated 
with basal IL-6 concentrations (/•= -0*43, P = 0-0001: 
r = —0*22, P = 0 05, respectively). No significant correlation 
was observed between rT3 and IL-6 (r = 0-21, P = 006). 
Discuss ion 
African trypanosomiasis is associated with extensive mono-
nuclear infiltration of organs invaded by the parasite (Mur-
ray, 1974; Morrison et al., 1981). In animals, inflammatory 
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changes in endocrine tissue have been described in the 
anterior and posterior pituitary (Ikede & Losos, 1975), the 
thyroid gland (Mutayoba et aL, 1988b), the adrenals (Ikede 
& Losos, 1975) and gonads (Ikede, 1979; Anosa & Kaneko, 
1984). Low fertility rates are a well known phenomenon in 
African trypanosomiasis and have been described in cattle, 
goats, sheep and rats. Biochemically, infected goats have low 
circulating oestradiol (Mutayoba et aL, 1988a) and testost-
erone concentrations (Waindi et aL, 1986) and low thyroxine 
concentrations (Mutayoba et aL, 1988b). In humans, endo-
crine abnormalities in SS have been less extensively investi-
gated. Pituitary fibrosis and thyroid atrophy were described 
in two fatal cases of cerebral SS (Hawking & Greenfield, 
1941). Loss of libido, amenorrhoea and impotence fre-
quently occur during the course of the disease (Ridet, 1953; 
Noireau et aL, 1988). Abnormalities in thyroid (Boersma et 
aL, 1989) and gonadal hormone secretion (Emeh & Nduka, 
1983; Hublart et aL, 1988) have been demonstrated in these 
patients, and we recently described a significant impairment 
of adrenocortical function in patients with SS, with 25% of 
the patients within the adrenocortical insufficiency range, 
which was most likely secondary to A C T H deficiency 
(Reincke et aL, 1992). We now show that, in addition to 
abnormalities in the pituitary-adrenal axis, the hypothala-
mic-pituitary-thyroid axis is impaired in SS, and this is 
correlated with circulating concentrations of inflammatory 
cytokines. 
Patients with unmedicated SS had slightly, but signifi-
cantly, elevated TSH concentrations, lowered fT3 and fT4 
concentrations and normal rT3 concentrations. The TSH 
response to T R H was not different from control subjects. 
These results are similar to reports by Hublart et aL (1988) 
and Boersma et aL (1989), who also described elevated TSH 
concentrations in the presence of low T3 and T4 concentra-
tions in smaller series of patients with SS. In addition, these 
authors found normal or low rT3 concentrations. The 
observed abnormalities in thyroid hormone secretion seem 
to be rather unusual and cannot be explained by either 
central hypothyroidism, primary hypothyroidism or the 
'cuthyroid-sick syndrome'. The last is characterized by very 
low T3 concentrations, low total T4 and normal fT4 levels, 
normal baseline TSH with a blunted response to stimulation 
with T R H and elevated rT3 concentrations due to an 
inhibition of the 5'-deiodinase which converts T3 to the 
inactive thyroid hormone 3,3 ,-triiodothyronine (Wartofsky 
& Burman, 1982; Wehmann et aL, 1985; Hamblin et aL, 
1986; Faber et aL, 1987; Felicetta, 1989). Although some of 
the thyroid hormone abnormalities observed in patients with 
SS may be attributed to the 4euthyroid-sick syndrome', 
elevated baseline TSH concentrations and normal rT3 
concentrations do not favour this explanation. 
Assuming a normally functioning hypothalamic-pituitary 
unit, primary hypothyroidism is accompanied by elevated 
baseline TSH concentrations and an exaggerated TSH 
response to T R H . Our patients had slightly elevated baseline 
TSH concentrations and a normal TSH response to T R H , 
excluding the presence of 'simple' primary hypothyroidism. 
However, pituitary TSH secretion may be abnormal in SS, 
because of parasitic infiltration of the pituitary gland, thus 
impairing the appropriate TSH surge in response to T R H in 
the background of primary hypothyroidism. Since A C T H 
(Reincke et aL, 1992) and LH/FSH (Emeh & Nduka, 1983; 
Hublart et aL, 1988) secretion is also impaired in African 
trypanosomiasis, patients with SS may suffer from mild 
panhypopituitarism. Low f T3 and f T4 concentrations in SS, 
therefore, are most likely the result of combined pituitary 
and peripheral hypothyroidism. In addition, hypothalamic 
hypothyroidism resulting from cerebral trypanosomiasis 
may contribute to the thyroid hormone abnormalities in SS. 
This condition is associated with slightly elevated baseline 
TSH concentrations (Ingbar, 1985) which have been attri-
buted to secretion of a form of TSH that is immunoreactive 
but has little or no biological activity due to reduced ability 
to bind to its receptor (Faglia et aL, 1983; Beck-Beccoz et aL, 
1985). Post-translational modifications of the TSH molecule 
associated with reduced biological activity have also been 
found in patients with non-thyroidal illness (Lee et aL, 1987). 
The pathogenesis of the impairment of the HPT axis 
function observed in SS is not clear. I t can be explained in 
two major ways which may not be mutually exclusive. First, 
it may be due to parasite infiltration and transient inflamma-
tory dysfunction of the hypothalamic-pituitary unit and/or 
of the thyroid gland. Animal and human data support this 
possibility (Hawking & Greenfield, 1941; Murray, 1974; 
Ikede & Losos, 1975; Morrison et aL, 1981; Mutayoba et aL, 
1988b). Thus, experimental infection with Trypanosoma 
brucei in sheep, resulted in acute coagulative necrosis of the 
adenohypophysis and leucocytic infiltration of the neuro-
hypophysis, with trypanosomas present in pituitary tissue 
(Ikede & Losos, 1975). In goats experimentally infected with 
Trypanosoma Congolese, chronic thyroiditis and very low T4 
concentrations have been described (Mutayoba er aL, 
1988b). In this paradigm the hypothyroidism was severe and 
permanent, different from the mild to moderate transient 
dysfunction that we observed. 
Second, elevated cytokine concentrations may suppress 
TSH and T3/T4 secretion in SS. Subcutaneously or intraperi-
toneally administered TNF-a and IL- lß decrease TSH and 
T3/T4 concentrations in rats (Dubuis et aL, 1988; Van Der 
Poll et aL, 1990) while the former causes also a reduction in 
hypothalamic T R H content (Pang et aL, 1989). In addition, 
TNF-a, a putative mediator of the euthyroid-sick syndrome, 
460 M. Reincke et al. Cl in ica l Endoc r i no l ogy (1993) 39 
inhibits the 5'-deiodinase of peripheral tissues (Ozawa et CiL, 
1988). IL-6 has been shown to inhibit the TSH-induced 
thyroid peroxidase gene expression and T3 secretion in a 
dose-dependant manner (Ahren, 1991; Tominaga et al, 
1991). The high circulating TNF-a and IL-6 levels in patients 
with SS correlated positively with baseline TSH and rT3 
concentrations, but negatively with f T3 and f T4 concentra-
tions. These data are compatible with a direct inhibitory 
effect of chronically elevated TNF-a and/or IL-6 on thyroid 
hormone secretion in SS, resulting in compensatory, albeit 
inadequate, elevation of TSH with potentially reduced 
bioactivity due to post-translational modifications (Faglia et 
al, 1983; Beck-Beccoz et al, 1985; Lee et al, 1987). High 
plasma inflammatory cytokine levels combined with the 
release of thyroid antigens due to parasitic thyroiditis could 
also provoke an autoimmune response with production of 
thyroid autoantibodies. However, thyroid antibodies meas-
ured in pooled serum samples were not elevated in our 
patients compared to controls (data not shown) which does 
not support this attractive hypothesis. 
The correlation between plasma cytokine and thyroid 
hormone concentrations was weak in this study. The interac-
tion between the immune system and the HPT axis in SS may 
be, therefore, more indirect. For example, elevation of 
inflammatory cytokines and suppression of the HPT axis in 
African trypanosomiasis can both be regarded as an index of 
disease activity. In this model, the observed correlation 
reflects more an association with the severity of the under-
lying illness rather than a direct inhibitory effect of TNF-a 
and/or IL-6 on the HPT axis. 
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